Article
The Prevalence of Subtypes of Type 2 Inflammation in an Unselected Population of Patients with Severe Asthma.
The journal of allergy and clinical immunology. In practice - 1 Mar 2021
Frøssing Laurits, Silberbrandt Alexander, Von Bülow Anna, Backer Vibeke, Porsbjerg Celeste
Abstract excerpt
BACKGROUND: With the introduction of different targeted therapies for type 2 (T2)-high asthma, there is an urgent need for markers to guide the choice of treatment. T2-high asthma includes different clinical phenotypes of asthma, but the prevalence and impact of activation of different T2 inflammatory pathways is unknown. OBJECTIVE: To describe the level of coexpression of clinically available T2 inflammatory...
Topics
Join the communities discussing this publication.